Sec Form 13G Filing - Bialecki Andrew filing for - 2026-08-05

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
X0202 SCHEDULE 13G/A 0001991099 XXXXXXXX LIVE 4 Series A common stock, par value $0.001 per share (the "Series A Common Stock") 06/30/2026 0001835830 Klaviyo, Inc. (the "Issuer") 49845K101 125 Summer Street, 6th Floor Boston MA 02110 Rule 13d-1(d) Bialecki Andrew X1 75326229.00 0.00 75326229.00 0.00 75326229.00 N 36.5 IN Klaviyo, Inc. (the "Issuer") 125 Summer Street, 6th Floor, Boston, Massachusetts, 02110 This statement is filed on behalf of Andrew Bialecki (the "Reporting Person"). The business address of the Reporting Person is c/o Klaviyo, Inc., 125 Summer Street, 6th Floor, Boston, MA 02110. The Reporting Person is a citizen of the United States of America. Y The ownership information below represents beneficial ownership of Series A Common Stock of the Issuer as of June 30, 2026, based on (i) 131,203,855 shares of Series A Common Stock outstanding as of June 30, 2026, as reported by the Issuer to the Reporting Person, plus (ii) an aggregate of 75,326,229 shares of Series A Common Stock issuable upon conversion of shares of the Issuer's Series B common stock, par value $0.001 per share (the "Series B Common Stock"), beneficially owned by the Reporting Person, which are deemed outstanding pursuant to SEC Rule 13-3(d)(1)(i) only for purposes of computing the percentage ownership of the Reporting Person. The Reporting Person may be deemed to be the beneficial owner of 75,326,229 shares of Series A Common Stock, which includes: (i) 64,731,589 shares of Series A Common Stock underlying shares of Series B Common Stock held directly by the Reporting Person, (ii) 43,218 shares of Series A Common Stock underlying shares of Series B Common Stock held by the Reporting Person's spouse, (iii) 7,517,410 shares of Series A Common Stock underlying shares of Series B Common Stock held by the Andrew P. Bialecki Grantor Retained Annuity Trust I of 2023, of which the Reporting Person serves as trustee, (iv) 2,000,000 shares of Series A Common Stock underlying shares of Series B Common Stock held by the Andrew P. Bialecki Grantor Retained Annuity Trust I of 2026, of which the Reporting Person serves as a trustee, (v) 517,006 shares of Series A Common Stock underlying shares of Series B Common Stock held by the Andrew P. Bialecki Irrevocable GST Trust of 2023, of which the Reporting Person's spouse serves as a trustee, and (vi) 517,006 shares of Series A Common Stock underlying shares of Series B Common Stock held by the Elizabeth L. Bialecki Irrevocable GST Trust of 2023, of which the Reporting Person serves as a trustee. 36.5% 75,326,229 0 75,326,229 0 Y N Y Y Y Y Y Bialecki Andrew /s/ Andrew Bialecki Andrew Bialecki 08/05/2026 primary_doc.xml